1. Home
  2. RES vs NVAX Comparison

RES vs NVAX Comparison

Compare RES & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$7.61

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.11

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
NVAX
Founded
1984
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
RES
NVAX
Price
$7.61
$8.11
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$5.64
$11.33
AVG Volume (30 Days)
2.2M
3.1M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
2.15%
N/A
EPS Growth
N/A
309.76
EPS
0.15
2.58
Revenue
$41,919,000,000.00
$1,123,479,000.00
Revenue This Year
$3.29
N/A
Revenue Next Year
$4.05
N/A
P/E Ratio
$49.77
$3.27
Revenue Growth
2216.21
64.69
52 Week Low
$4.18
$5.80
52 Week High
$7.53
$11.85

Technical Indicators

Market Signals
Indicator
RES
NVAX
Relative Strength Index (RSI) 63.68 40.20
Support Level $5.19 $8.01
Resistance Level N/A $8.45
Average True Range (ATR) 0.30 0.35
MACD 0.05 0.04
Stochastic Oscillator 79.22 29.30

Price Performance

Historical Comparison
RES
NVAX

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: